Bumrungrad International Hospital was the first in Asia to earn JCI accreditation, reflecting strict international safety standards. Its oncology programme uses innovative drugs including immunotherapy, targeted cancer inhibitors, and US FDA-approved biologics. Treatment is supported by IBM Watson for Oncology for personalised recommendations. The clinic has a regular flow of Australian patients, offers dedicated visa extension counters, and maintains no waiting lists for its services.